Details

Autor(en) / Beteiligte

• Greenwood, John C.
• Talebi, Fatima M.
• Jang, David H.
• Spelde, Audrey E.
• Tonna, Joseph E.
• Gutsche, Jacob T.
• Horak, Jiri
• Acker, Michael A.
• Kilbaugh, Todd J.
• Shofer, Frances S.
• Augoustides, John G. T.
• Bakker, Jan
• Brenner, Jacob S.
• Muzykantov, Vladimir R.
• Abella, Benjamin S.

Titel

Topical nitroglycerin to detect reversible microcirculatory dysfunction in patients with circulatory shock after cardiovascular surgery: an observational study

Ist Teil von

• Scientific reports, 2022-09, Vol.12 (1), p.15257-15257, Article 15257

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Persistent abnormalities in microcirculatory function are associated with poor clinical outcomes in patients with circulatory shock. We sought to identify patients with acutely reversible microcirculatory dysfunction using a low-dose topical nitroglycerin solution and handheld videomicroscopy during circulatory shock after cardiac surgery. Forty subjects were enrolled for the study, including 20 preoperative control and 20 post-operative patients with shock. To test whether microcirculatory dysfunction is acutely reversible during shock, the sublingual microcirculation was imaged with incident dark field microscopy before and after the application of 0.1 mL of a 1% nitroglycerin solution (1 mg/mL). Compared to the control group, patients with shock had a higher microcirculation heterogeneity index (MHI 0.33 vs. 0.12, p  < 0.001) and a lower microvascular flow index (MFI 2.57 vs. 2.91, p  < 0.001), total vessel density (TVD 22.47 vs. 25.90 mm/mm 2 , p  = 0.005), proportion of perfused vessels (PPV 90.76 vs. 95.89%, p  < 0.001 ) and perfused vessel density (PVD 20.44 vs. 24.81 mm/mm 2 , p  < 0.001). After the nitroglycerin challenge, patients with shock had an increase in MFI (2.57 vs. 2.97, p  < 0.001), TVD (22.47 vs. 27.51 mm/mm 2 , p  < 0.009), PPV (90.76 vs. 95.91%, p  < 0.001), PVD (20.44 vs. 26.41 mm/mm 2 , p  < 0.001), venular RBC velocity (402.2 vs. 693.9 µm/s, p  < 0.0004), and a decrease in MHI (0.33 vs. 0.04, p  < 0.001. Thirteen of 20 patients showed a pharmacodynamic response, defined as an increase in PVD > 1.8 SD from shock baseline. Hemodynamics and vasoactive doses did not change during the 30-min study period. Our findings suggest a topical nitroglycerin challenge with handheld videomicroscopy can safely assess for localized recruitment of the microcirculatory blood flow in patients with circulatory shock and may be a useful test to identify nitroglycerin responsiveness.